COMP <GO>
SOLS vs EMN // EV/EBITDA & P/E VALUATION
Solstice Advanced Materials Inc. (NASDAQ) VS. Eastman Chemical Company (NYSE) • 15-METRIC TALLY: SOLS 8
— EMN 6
▲ EV/EBITDA & P/E VALUATION LEADER: EMN
LAST: $60.55 (-3.21%) • MKT CAP: $9.94B
valuation
19.8x
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
valuation
10.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SOLS VS. EMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SOLS | EMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.20% | 21.10% | +11.10 | SOLS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | 4.80% | +3.20 | SOLS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 19.8x | 10.9x | +8.90 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 1.20% | 5.46% | -4.26 | EMN | /fcf-yield <GO> |
| Operating Margin | 7.40% | 6.60% | +0.80 | SOLS | /operating-margins <GO> |
| Net Profit Margin | 6.10% | 5.40% | +0.70 | SOLS | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | -6.70% | +9.80 | SOLS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 11.50% | 4.90% | +6.60 | SOLS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 2.28 | +0.11 | SOLS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | EMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 60.3 | -5.30 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.06 | -0.05 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.0x | 15.3x | +23.70 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.94B | $7.77B | $2.17B | SOLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SOLS REV | EMN REV | SOLS GROSS % | EMN GROSS % | SOLS FCF | EMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.89B | $8.75B | 32.2% | 21.1% | $119.0M | $424.0M |
| FY 2024 | $3.77B | $9.38B | 34.6% | 24.4% | $546.0M | $688.0M |
| FY 2023 | $3.65B | $9.21B | — | — | $595.8M | $959.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SOLS // BETA 1.01
EMN // BETA 1.06